knowledge -WSS

knowledge

author：knowledge 2025-08-24 04:06:27 - browse：3451

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： ‘The Bear’ and hospitality in hospitals

explore

WSS

Medicare drug price negotiation hasn't dried up venture capital

What STAT readers think about the FDA and patient advocacy

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Keeping primary care docs in field isn't impossible, says AAFP CEO

What STAT readers think about the FDA and patient advocacy

Bristol Myers buys into radiopharmaceuticals with RayzeBio

hotspot

knowledge

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

In age of alternative facts, a scholarly course on calling out crap

Biden praises World Series champion Astros for impact off the field during White House celebration

Duchenne breakthrough therapy leaves behind pioneering families

Former Georgia lieutenant governor says he received grand jury subpoena

23andMe had bad news about my health. I wish a person had delivered it

Lessons Learned: This is why you network to find that industry job you want

Tori Bowie and the unacceptable rates of Black maternal death

Drinking less cuts risk of oral cavity, esophageal cancer: Report

hotspot

Lessons Learned: This is why you network to find that industry job you want

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

An Ebola outbreak presents a new mystery involving children

Prime Medicine, Myeloid Therapeutics clash over genome

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Judge rejects Trump's counterclaim against E. Jean Carroll

explore

explore

explore

leisure time